• 

  Scripps Research launches study to reduce hospitalization of immunocompromised people with COVID-19

  In partnership with Cue Health, the study will deploy at-home COVID-19 tests, on-demand telemedicine and delivery of antiviral medication in an effort to lessen severe disease outcomes.

• 

  Scripps Research awarded NIH grant to enhance biosafety level 3 facility to address viruses of pandemic concern

  The $3.8 million award will expand the institute’s research programs aimed at identifying therapeutics for various RNA viruses.

• 

  Scripps Research receives $2.5M CDC contract for SARS-CoV-2 surveillance program

  Work will include fast analyses of virus transmission in the San Diego area and across the U.S.- Mexico border.

• 

  New drug has potential to turn COVID-19 virus against itself

  Scripps Research team showed that a variation of an already FDA-approved therapeutic for neurological disease can block COVID-19 infection in animals.

• 

  Detecting the earliest population changes of COVID-19 activity with wearable devices

  New data from Scripps Research shows how sensors can provide real-time COVID-19 tracking and forecasting

• 

  Scripps Research scientists identify how SARS-CoV-2 spreads in the Middle East

  Findings highlight biases in viral sampling and urgent need for better global health infrastructure.

• 

  Scripps Research scientists discover antibodies that induce broad immunity against SARS viruses, including emerging variants

  Finding opens the door for new vaccine approaches and strategies.

• 

  Scientists develop tools for early detection of SARS-CoV-2 variants in wastewater

  New tools developed at Scripps Research and UC San Diego are helping public health officials around the world get vital information about pathogen variants from wastewater.

• 

  Scripps Research and GISAID release application programming interface (API) for accessing COVID-19 variant data

  Open science collaboration will support global genomic surveillance efforts to track coronavirus variants.

• 

  COVID-19 patient antibodies point researchers toward broad coronavirus vaccines

  Certain antibodies isolated from people who had recovered from COVID-19 and were vaccinated have the ability to neutralize variety of coronaviruses.